Bibliography
- Wild S, Roglic G, Green A, Global prevalence of diabetes: estimates for 2000 and projections for 2030. Diabetes Care 2004;27:1047-53
- Klein R, Klein BE, Moss SE, The Wisconsin epidemiologic study: II prevalence and risk of diabetic retinopathy when age at diagnosis is less than thirty years. Arch Ophthalmol 1984;102:520-6
- Harding S, Greenwood R, Aldington S, Diabetic retinopathy grading and disease management working party. Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet Med 2003;20:965-71
- UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53
- Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the diabetes control and complications trial. Ophthalmology 1995;102:647-61
- Klein R, Sharrett AR, Klein BE, The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : the atherosclerosis risk in communities study. Ophthalmology 2002;109:1225-34
- Stefansson E, Bek T, Porta M, Screening and prevention of diabetic blindness. Acta Ophthalmol Scand 2000;78:374-85
- Harding S, Garvican L, Talbot J. The impact of national diabetic retinopathy screening on ophthalmology: the need for urgent planning. Eye (Lond) 2005;19:1009-11
- Anker P, Mulcahy H, Stroun M. Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies? Int J Cancer 2003;103:149-52
- Lo YMD, Chiu RWK. Prenatal diagnosis: progress through plasma nucleic acids. Nat Rev Genet 2007;8:71-7
- Lo YMD, Tein MS, Pang CC, Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients. Lancet 1998;351:1329-30
- Lo YMD, Rainer TH, Chan LYS, Plasma DNA as a prognostic marker in trauma patients. Clin Chem 2000;46:319-23
- Wijeratne S, Butt A, Burns S, Cell-free plasma DNA as a prognostic marker in intensive treatment unit patients. Ann NY Acad Sci 2004;1022:232-8
- Grammatopoulos D, Elliott Y, Smith SC, Measurement of thyroglobulin mRNA in peripheral blood as an adjunctive test for monitoring thyroid cancer. Mol Pathol 2003;56:162-6
- Fung EC, Butt A, Carr-White G, Circulating microRNAs in the assessment of heart failure and microRNa-133A as a potential biomarker of cardiac remodeling. J Nucl Acid Res 2011;2(1S):35
- Agalou S, Butt AN, Chowienczyk P, Hypertension and circulating mRNA for 11beta-hydroxysteroid dehydrogenase type II. Ann NY Acad Sci 2008;1137:290-5
- Hamaoui K, Butt A, Powrie J, Swaminathan R. Concentration of circulating rhodopsin mRNA in diabetic retinopathy. Clin Chem 2004;50:2152-5
- Shalchi Z, Sandhu HS, Butt AN, Retina-specific mRNA in the assessment of diabetic retinopathy. Ann NY Acad Sci 2008;1137:253-7
- Ganong WF. Review of Medical Physiology. The McGraw-Hill Companies; Singapore: 2005. p. 157-9
- Imamura Y, Kubota R, Wang Y, Human retina-specific amine oxidase (RAO): cDNA cloning, tissue expression, and chromosomal mapping. Genomics 1997;40:277-83
- Rainer TH, Wong LK, Lam W, Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin Chem 2003;49:562-9
- Holford NC, Sandhu HS, Thakkar H, Stability of beta-actin mRNA in plasma. Ann NY Acad Sci 2008;1137:108-11
- Chelly J, Concordet JP, Kaplan JC, Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci USA 1989;86:2617-21
- Holford NC, Ramoutar A, Butt AN, Normalization of circulating nucleic acid results. Ann NY Acad Sci 2008;1137:112-18
- Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000;25:169-93